Principle 2 – Clinical governance processes for doctors, AAs and PAs are managed and monitored with a view to continuous improvement and quality assurance
- Summary
- How to use this handbook
- Principle 1 – An effective environment
- Principle 2 – Continuous improvement
Outcome 2a. Internal and external quality assurance is undertaken which ensures the robustness of clinical governance processes for doctors, AAs and PAs.
Description
Your organisation periodically seeks internal and external assurance that clinical governance arrangements for doctors, AAs and PAs are operating effectively, and generating accurate, timely and reliable data to support continuous monitoring.
Your organisation ensures recommendations from quality assurance exercises are taken forward and reviewed on a regular basis, and measures the impact of quality improvement activity on improved patient care.
Your organisation encourages lay involvement in their quality assurance processes, to provide independent scrutiny and challenge, and to increase public confidence that local governance is robust.
Local medical education providers meet the requirements within our Promoting Excellence guidance.
Outcome 2b. Learning is used to continually improve clinical governance processes for doctors, AAs and PAs.
Description
Your organisation demonstrates a commitment to making clinical governance processes for doctors, AAs and PAs streamlined and robust, by planning, delivering and reviewing their continuous improvement.
Your organisation makes sure arrangements or processes are in place so that:
- lessons are learnt from analysing clinical governance processes including: adverse incidents and near misses, matters raised by staff speaking up, and revalidation decisions around deferral and non-engagement
- lessons are shared with the healthcare team
- concrete action follows on from learning
- practice is changed where needed.
Your organisation incorporates learning drawn from your own organisation’s arrangements and experience of clinical governance, as well as from good practice in other organisations and feedback from patients and patient groups.
The triangulation of outputs from different clinical governance processes is used to identify areas for learning and improvement.
Outcome 2c. Risks associated with clinical governance are monitored by your Board and managed appropriately.
Description
Your board is proactive in identifying, monitoring and managing risks to clinical governance arrangements as they apply to doctors, AAs and PAs – acknowledging through your response that the risks may be different for each group.
Your organisation uses available information to inform their clinical governance arrangements for doctors, AAs and PAs, such as the GMC’s organisational dashboard for revalidation and fitness to practise.
